fda warning compounded semaglutide safety 2024 2025 National Hispanic Medical Association | After GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and As interest in weight loss

Both vendors clearly state these products are for laboratory research only

That is the honest assessment

The obesity-related conditions these medications treat represent actual risks causing actual harm to actual patients right now

Proper technique, on the other hand, preserves this intricate structure, ensuring the peptide you use in your research is exactly what you intended it to be

These agents also offer additional benefits, such as neuroprotection, anti-inflammatory properties, and reductions in NAFLD-related risks, further broadening their clinical utility (23)(41)

Standard GLP-1 dosing is built for maximum weight loss